Pharmaceutical Preparation Manufacturing
Madrigal Pharmaceuticals Inc
% of Portfolio
35.3%
Average Buy Price
$222.20
+34.8%
Current Price
$299.57
Q3 2024
Increased shares by 10.4%
35.3% of Portfolio
Added 10.4% in Q3 2024
Avg closing price
Price range
See more trades by signing up for free
Google
Facebook
Or continue with email
View all investments of John Paulson
